Cardiovascular Systems Inc Quarterly Amortization of Intangible Assets in USD from Q3 2012 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Cardiovascular Systems Inc quarterly/annual Amortization of Intangible Assets history and growth rate from Q3 2012 to Q4 2022.
  • Cardiovascular Systems Inc Amortization of Intangible Assets for the quarter ending December 31, 2022 was $345K, a 0.29% decline year-over-year.
  • Cardiovascular Systems Inc Amortization of Intangible Assets for the twelve months ending December 31, 2022 was $1.38M, a 9.94% increase year-over-year.
  • Cardiovascular Systems Inc annual Amortization of Intangible Assets for 2022 was $1.34M, a 10.4% increase from 2021.
  • Cardiovascular Systems Inc annual Amortization of Intangible Assets for 2021 was $1.22M, a 1.46% decline from 2020.
  • Cardiovascular Systems Inc annual Amortization of Intangible Assets for 2020 was $1.23M, a 317% increase from 2019.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $1.38M $345K -$1K -0.29% Oct 1, 2022 Dec 31, 2022 10-Q 2023-02-09
Q3 2022 $1.38M $346K +$42K +13.8% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $1.34M $346K +$42K +13.8% Apr 1, 2022 Jun 30, 2022 10-K 2022-08-18
Q1 2022 $1.3M $346K +$42K +13.8% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $1.26M $346K +$42K +13.8% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-09
Q3 2021 $1.22M $304K $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $1.22M $304K -$22K -6.75% Apr 1, 2021 Jun 30, 2021 10-K 2022-08-18
Q1 2021 $1.24M $304K -$33K -9.79% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $1.27M $304K -$33K -9.79% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-03
Q3 2020 $1.3M $304K +$70K +29.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $1.23M $326K +$265K +434% Apr 1, 2020 Jun 30, 2020 10-K 2022-08-18
Q1 2020 $969K $337K +$210K +165% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $759K $337K +$282K +513% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-04
Q3 2019 $477K $234K +$181K +342% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $296K $61K Apr 1, 2019 Jun 30, 2019 10-K 2021-08-19
Q1 2019 $127K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $55K Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-06
Q3 2018 $53K +$4K +8.16% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q3 2017 $49K -$758K -93.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q3 2016 $807K +$721K +838% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q3 2015 $86K +$45K +110% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q3 2014 $41K +$13K +46.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q3 2013 $28K -$6K -17.6% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q3 2012 $34K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.